The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.
Guide to Receptors and Channels (GRAC), 5th edition
Open accessAbstract
The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Functional CRF 1 receptors are essential for the activation of the endocrine response to stress [169].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citationThe oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14
Cited by
Sorted by citations
Items 801–900 of 1,000
Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents
Scherer, D. J., Hassel, D., Bloehs, R., Zitron, E., von Löwenstern, K., Seyler, C., Thomas, D., Konrad, F. M., Bürgers, H. F., Seemann, G., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00018.x · Cited by 41
Maguire, E. P., Mitchell, E. A., Greig, S. J., Corteen, N. L., Balfour, D. J. K., Swinny, J. D., Lambert, J. J., & Belelli, D. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.326 · Cited by 42
Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway
Fukuyama, K., Tanahashi, S., Hoshikawa, M., Shinagawa, R., & Okada, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.002 · Cited by 41
Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands
Rodrigues, T., Hauser, N., Reker, D., Reutlinger, M., Wunderlin, T., Hamon, J., Koch, G., & Schneider, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201410201 · Cited by 41
Functional and morphological properties of pericytes in suburothelial venules of the mouse bladder
Hashitani, H., Mitsui, R., Shimizu, Y., Higashi, R., & Nakamura, K. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02125.x · Cited by 41
Yudin, Y. K., & Rohács, T. (2018) · Molecular Pain · doi:10.1177/1744806918763646 · Cited by 40
Chung, H., Dai, Z., Wu, B., Yeh, J., Chai, C., Chu, K., Liu, C.-P., & Chen, I. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00740.x · Cited by 41
Ion channel remodeling in gastrointestinal inflammation
Akbarali, H. I., Hawkins, E. G., Ross, G. R., & Kang, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01560.x · Cited by 41
Nie, Z., Scott, G. D., Weis, P., Itakura, A., Fryer, A. D., & Jacoby, D. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01393.x · Cited by 41
Male-Female Differences in Upregulation of Vasoconstrictor Responses in Human Cerebral Arteries
Ahnstedt, H. W., Cao, L., Krause, D. N., Warfvinge, K., Säveland, H., Nilsson, O., & Edvinsson, L. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062698 · Cited by 41
Potassium channels in health, disease & development of channel modulators.
Selvarajan, S., & Dkhar, S. A. (2009) · PubMed · Cited by 41
Ni, J., Zhu, Y., Zhong, X., Ding, Y. J., Hou, L., Tong, X., Tang, W., Ono, S., Yang, Y., & Zuo, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00528.x · Cited by 40
PKC‐dependent activation of human K2P18.1 K+ channels
Rahm, A., Gierten, J., Kisselbach, J., Staudacher, I., Staudacher, K., Schweizer, P. A., Becker, R., Katus, H. A., & Thomas, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01813.x · Cited by 40
Burk, O., Piedade, R., Ghebreghiorghis, L., Fait, J., Nussler, A. K., Gil, J. P., Windshügel, B., & Schwab, M. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02033.x · Cited by 40
Slack, R. J., Russell, L., Hall, D. A., Luttmann, M. A., Ford, A., Saunders, K. A., Hodgson, S., Connor, H., Browning, C. J., & Clark, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01285.x · Cited by 40
Intermediate‐conductance calcium‐activated potassium channels participate in neurovascular coupling
Longden, T. A., Dunn, K., Draheim, H. J., Nelson, M. T., Weston, A. H., & Edwards, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01447.x · Cited by 39
Pinho, J., de Medeiros, M. A. A., Capettini, L. D. S. A., Rezende, B., Campos, P. P., Andrade, S. P., Côrtes, S. F., Cruz, J. S., & Lemos, V. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00955.x · Cited by 40
The carbon monoxide donor, CORM-2, is an antagonist of ATP-gated, human P2X4 receptors
Wilkinson, W. J., & Kemp, P. J. (2011) · Purinergic Signalling · doi:10.1007/s11302-010-9213-8 · Cited by 40
Müller, A., Kleinau, G., Piechowski, C. L., Müller, T. D., Finan, B., Pratzka, J., Grüters, A., Krude, H., Tschöp, M. H., & Biebermann, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053347 · Cited by 40
Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons
Gaisano, G., park, S. J., Daly, D., & Beyak, M. J. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01430.x · Cited by 40
Ohtsubo, S., Fujita, T., Matsushita, A., & Kumamoto, E. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.127 · Cited by 40
Purinergic signalling mobilizes mitochondrial Ca2+in mouse Sertoli cells
Veitinger, S., Veitinger, T., Cainarca, S., Fluegge, D., Engelhardt, C. H., Lohmer, S., Hatt, H. H., Corazza, S., Spehr, J., Neuhaus, E. M., et al. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.216309 · Cited by 40
Mehta, D., & Granstein, R. D. (2019) · Dermatology · doi:10.1159/000496538 · Cited by 40
OX1 orexin/hypocretin receptor activation of phospholipase D
Jäntti, M. H., Putula, J., Somerharju, P. J., Ma, F., & Kukkonen, J. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01565.x · Cited by 41
Schulz, S., Heidmann, K. E., Mike, Á., Klaft, Z., Heinemann, U., & Gerevich, Z. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02107.x · Cited by 41
Somatostatin inhibits colon cancer cell growth through cyclooxygenase‐2 downregulation
Colucci, R., Blandizzi, C., Ghisu, N., Florio, T., & Tacca, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.268 · Cited by 41
Klumpers, L. E., Roy, C., Ferron‐Brady, G., Turpault, S., Poitiers, F., Pinquier, J., van Hasselt, J. G. C., Zuurman, L., Erwich, F. A. S., & van Gerven, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12071 · Cited by 40
Ikeda‐Matsuo, Y., Tanji, H., Ota, A., Hirayama, Y., Uematsu, S., Akira, S., & Sasaki, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00711.x · Cited by 42
Krøigaard, C., Dalsgaard, T., Nielsen, G., Laursen, B. E., Pilegaard, H. K., Köhler, R., & Simonsen, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01986.x · Cited by 40
Fagerholm, V., Scheinin, M., & Haaparanta‐Solin, M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.186 · Cited by 40
Vanattou‐Saïfoudine, N., McNamara, R., & Harkin, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00660.x · Cited by 39
Chen, X., Shan, H., Zhao, J., Hong, Y., Bai, Y., Sun, I., Pan, Z., Zhang, Y., Yang, B., & Du, Z. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000324005 · Cited by 39
Jin, H., Lee, K.-W., Song, M.-J., Hyeon, Y.-J., Hwang, J.-Y., Jang, C., Ahn, J., Jeon, S.-H., Kim, H. U., Kim, Y., et al. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.039 · Cited by 39
Matott, M. P., Kline, D. D., & Hasser, E. (2017) · Journal of Physiology · doi:10.1113/jp274620 · Cited by 28
Giricz, Z., Görbe, A., Pipis, J., Burley, D. S., Ferdinandy, P., & Baxter, G. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00424.x · Cited by 39
Novel Mutation in Potassium Channel related Gene KCTD7 and Progressive Myoclonic Epilepsy
Krabichler, B., Rostasy, K. M., Baumann, M., Karall, D., Scholl‐Bürgi, S., Schwarzer, C., Gautsch, K., Spreiz, A., Kotzot, D., Zschocke, J., et al. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00710.x · Cited by 39
Orie, N. N., Thomas, A., Perrino, B., Tinker, A., & Clapp, L. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00221.x · Cited by 39
Garção, P., Szabó, E. C., Wopereis, S., de Castro, A. A., Tomé, Â. R., Prediger, R. D., Cunha, R. A., Agostinho, P. M., & Köfalvi, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12234 · Cited by 40
Tan, Y. R., Chiow, K. H., Huang, D., & Wong, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00627.x · Cited by 38
McKay, S., Griffiths, N., Butters, P., Thubron, E., Hardingham, G. E., & Wyllie, D. J. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01748.x · Cited by 38
Identification of α 1L ‐adrenoceptor in mice and its abolition by α 1A ‐adrenoceptor gene knockout
Muramatsu, I., Morishima, S., Suzuki, F., Yoshiki, H., Anisuzzaman, A. S. M., Tanaka, T., Rodrigo, M. C., Myagmar, B., & Simpson, P. C. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.360 · Cited by 39
Sauvageau, S., Thorin, É., Villeneuve, L. R., & Dupuis, J. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.01.006 · Cited by 39
Haque, S., Dashwood, M. R., Heetun, M., Shiwen, X., Farooqui, N., Ramesh, B., Welch, H., Savage, F. J., Ogunbiyi, O. A., Abraham, D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0975 · Cited by 39
Spitzmaul, G. F., Gumilar, F., Dilger, J. P., & Bouzat, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00214.x · Cited by 39
Meens, M., Mattheij, N. J. A., van Loenen, P. B., Spijkers, L. J. A., Lemkens, P., Nelissen, J., Compeer, M. G., Alewijnse, A. E., & Mey, J. G. R. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01774.x · Cited by 40
Recombinant human soluble thrombomodulin prevents peripheral HMGB 1‐dependent hyperalgesia in rats
Tanaka, J., Seki, Y., Ishikura, H., Tsubota, M., Sekiguchi, F., Yamaguchi, K., Murai, A., Umemura, T., & Kawabata, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12396 · Cited by 38
Lam, F. F. Y., & Ng, E. S. K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00586.x · Cited by 38
Endogenous PYY and GLP ‐1 mediate l ‐glutamine responses in intestinal mucosa
Joshi, S., Tough, I. R., & Cox, H. M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12352 · Cited by 38
Adage, T., Piccinini, A. M., Falsone, A., Trinker, M. U., Robinson, J. I., Gesslbauer, B., & Kungl, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02089.x · Cited by 38
Size does matter! Label-free detection of small molecule–protein interaction
Fechner, P., Bleher, O., Ewald, M., Freudenberger, K., Furin, D., Hilbig, U., Kolarov, F., Krieg, K., Leidner, L., Markovic, G., et al. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7834-4 · Cited by 38
Cuzzoni, E., Iudicibus, S. D., Bartoli, F., Ventura, A., & Decorti, G. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04130.x · Cited by 38
Nie, Z., Jacoby, D. B., & Fryer, A. D. (2008) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00045.x · Cited by 38
Roscioni, S. S., Dekkers, B. G. J., Prins, A. G., Menzen, M. H., Meurs, H., Schmidt, M., & Maarsingh, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01011.x · Cited by 38
Holden, N. S., Rider, C. F., Bell, M., Velayudhan, J., King, E., Kaur, M., Salmon, M., Giembycz, M. A., & Newton, R. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00708.x · Cited by 38
Detergent-free extraction of a functional low-expressing GPCR from a human cell line
Juarez, J. F. B., Muñoz-García, J. C., Reis, R. I., Henry, A. J., McMillan, D., Kriek, M., Wood, M. D., Vandenplas, C., Sands, Z. A., Castro, L., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183152 · Cited by 38
Carbon monoxide is a rapid modulator of recombinant and native P2X2ligand‐gated ion channels
Wilkinson, W., Gadeberg, H. C., Harrison, A., Allen, N., Riccardi, D., & Kemp, P. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00354.x · Cited by 38
Carrasco-Jimenez, M. P., Jiménez‐López, J. M., Ríos‐Marco, P., Segovia, J. L., & Marco, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00689.x · Cited by 38
Milara, J., Ortiz, J. L., Juan, G., Guijarro, R., Almudéver, P., Martorell, M., Morcillo, E. J., & Cortijo, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00979.x · Cited by 38
Bourikas, L. A., Kolios, G. C., Valatas, V., Notas, G., Drygiannakis, I., Pelagiadis, I., Manousou, P., Klironomos, S., Mouzas, I., & Kouroumalis, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00161.x · Cited by 38
Kast, R. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00923.x · Cited by 39
Duarte‐Araújo, M., Nascimento, C., Timóteo, M. A., Magalhães-Cardoso, M. T., & Correia‐de‐Sá, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00058.x · Cited by 38
Bexis, S., & Docherty, J. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00186.x · Cited by 38
Identification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi
Prole, D. L., & Taylor, C. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042404 · Cited by 37
Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 – 2010)
Malherbe, P., Ballard, T. M., & Ratni, H. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.568482 · Cited by 38
Lu, F., Fernandes, S. M., & Davis, A. E. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2009 · Cited by 38
LYCHOS is a human hybrid of a plant-like PIN transporter and a GPCR
Bayly-Jones, C., Lupton, C. J., Keen, A. C., Dong, S., Mastos, C., Luo, W., Qian, C., Jones, G. D., Venugopal, H., Chang, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08012-9 · Cited by 36
Cheng, W., Lu, P., Hsiao, M., Hsiao, C., Ho, W., Cheng, P., Lin, C., Hong, L., & Tseng, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01832.x · Cited by 37
Hofmann, U., Hu, K., Walter, F. G., Burkard, N., Ertl, G., Bauersachs, J. K., Ritter, O., Frantz, S., & Bonz, A. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00767.x · Cited by 37
Ligand determinants of fatty acid activation of the pronociceptive ion channel TRPA1
Redmond, W. J., Gu, L., Camo, M., McIntyre, P., & Connor, M. A. (2014) · PeerJ · doi:10.7717/peerj.248 · Cited by 37
Chung, F., Eyal, S., Muzi, M., Link, J. M., Mankoff, D. A., Kaddoumi, A., O’Sullivan, F., Hsiao, P., & Unadkat, J. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00538.x · Cited by 37
Sodium Channels in Pain and Cancer
Luiz, A. P., & Wood, J. N. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2015.12.006 · Cited by 37
New Prospect for Cancer Cachexia: Medical Cannabinoid
Wang, J., Wang, Y., Tong, M., Pan, H., & Li, D. (2019) · Journal of Cancer · doi:10.7150/jca.28246 · Cited by 37
A Supervised Molecular Dynamics Approach to Unbiased Ligand–Protein Unbinding
Deganutti, G., Moro, S., & Reynolds, C. A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b01094 · Cited by 36
MacMillan, D., & McCarron, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00369.x · Cited by 37
Dehvari, N., Hutchinson, D. S., Nevzorova, J., Dallner, O. S., Sato, M., Kočan, M., Merlin, J., Evans, B. A., Summers, R. J., & Bengtsson, T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01647.x · Cited by 37
Nazarian, A., Christianson, C. A., Hua, X., & Yaksh, T. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.341 · Cited by 37
Yoon, S., Roh, D., Seo, H.-S., Kang, S., Han, H. J., Beitz, A. J., & Lee, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00197.x · Cited by 37
Yang, X., Xin, W., Yang, X., Kuno, A., Rich, T. C., Cohen, M. V., & Downey, J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01288.x · Cited by 37
Gan, J., Greenwood, S., Cobb, S., & Bushell, T. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01293.x · Cited by 37
Biffen, M., Matsui, H., Edwards, S., Leishman, A. J., Eiho, K., Holness, E., Satterthwaite, G., Doyle, I., Wada, H., Fraser, N., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01790.x · Cited by 37
Ito, M., Ishihara, A., Gomori, A., Matsushita, H., Ito, M., Jm, M., Marsh, D. J., Haga, Y., Iwaasa, H., Tokita, S., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00536.x · Cited by 37
VIP modulates the pro‐inflammatory maternal response, inducing tolerance to trophoblast cells
Fraccaroli, L., Alfieri, J. A., Larocca, L., Calafat, M., Roca, V., Lombardi, E., Ramhorst, R., & Leirós, C. P. (2008) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00055.x · Cited by 37
Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids.
Staniaszek, L., Norris, L., Kendall, D., Barrett, D., & Chapman, V (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00703.x · Cited by 36
Hu, M., Gopalakrishnan, M., & Li, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00474.x · Cited by 36
Sugidachi, A., Ohno, K., Ogawa, T., Jakubowski, J. A., Hashimoto, M., & Tomizawa, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12108 · Cited by 36
Adrenoceptor Function and Expression in Bladder Urothelium and Lamina Propria
Moro, C., Tajouri, L., & Chess‐Williams, R. (2012) · Urology · doi:10.1016/j.urology.2012.09.011 · Cited by 36
The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough
Makwana, R., Venkatasamy, R., Spina, D., & Page, C. P. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221283 · Cited by 36
Corronc, H. L., Rigo, J., Branchereau, P., & Legendre, P. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8185-1 · Cited by 39
Trafficking of Neuronal Two Pore Domain Potassium Channels
Mathie, A. A., Rees, K. A., Hachmane, M. F. E., & Veale, E. L. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246146 · Cited by 35
Self-citationBenallegue, N., Mazzaferro, S., Alcaino, C., & Bermúdez, I. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12268 · Cited by 36
Ulu, N., Gürdal, H., Landheer, S. W., Duin, M., Guc, M. O., Buikema, H., & Henning, R. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00829.x · Cited by 36
Buenestado, A., Grassin‐Delyle, S., Reguigne-Arnould, I., Besnard, F., Naline, E., Blouquit‐Laye, S., Chapelier, A. R., Bellamy, J., & Devillier, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00614.x · Cited by 38
Harmati, G., Bányász, T., Bárándi, L., Szentandrássy, N., Horváth, B., Szabó, G., Szentmiklósi, J., Szénási, G., Nánási, P. P., & Magyar, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01092.x · Cited by 36
Povstyan, O. V., Harhun, M. I., & Gordienko, D. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01169.x · Cited by 36
Sala, M., Braida, D., Pucci, L., Manfredi, I., Marks, M. J., Wageman, C. R., Grady, S. R., Loi, B., Fucile, S., Fasoli, F., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02204.x · Cited by 36
Structure–function relationships of the N‐terminus of receptor activity‐modifying proteins
Qi, T., & Hay, D. L. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00541.x · Cited by 36
Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta
Quang, T. T., Rozec, B. R., Audigane, L., & Gauthier, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00074.x · Cited by 36
Xu, Y., Zhang, R., Chen, J., Zhang, Q., Wang, J., Hu, J., Guan, X., Jin, L., Fu, H., Gui, B., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00210.x · Cited by 36
The IUPHAR/BPS Guide to PHARMACOLOGY in 2026
Harding, S. D., Armstrong, J. F., Faccenda, E., Southan, C., Alexander, S. P. H., Davenport, A. P., Spedding, M., & Davies, J. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1067 · Cited by 35
Self-citationArachidonic acid release mediated by OX1 orexin receptors
Turunen, P. M., Ekholm, M. E., Somerharju, P. J., & Kukkonen, J. P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00535.x · Cited by 35
Metadata
- Authors
- Alexander, S., Mathie, A., & Peters, J.
- Affiliations
- University of Nottingham (GB)
- Medway School of Pharmacy (GB)
- University of Dundee (GB)
- ORCID
- Mathie, A
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-11
- Volume
- 164
- Issue
- s1
- Pages
- S1-324
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC3315626
- OpenAlex
- W2069380892
- Cited by
- 1,947
- References
- 2
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
- FWCI
- 109.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Kent Academic Repository (University of Kent) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
- MeSH terms
- Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review